Generic Name and Formulations:
Water, hydrofluorocarbon 134a (propellant), glycerin, ethylhexyl palmitate, cetearyl alcohol, propylene glycol, dicetyl phosphate, theobroma grandiflorum seed butter, petrolatum, dimethicone, steareth-10, ceteareth-10 phosphate, tocopheryl acetate, methylparaben, disodium EDTA, propylparaben, sodium hyaluronate and sodium hydroxide; emollient foam.
Encore Dermatology, Inc.
Indications for HYLATOPIC:
Dermatitis (including radiation dermatitis). Dry skin.
Adults and Children:
Apply and massage into affected area 3 times daily or as needed. Broken skin: may be occluded.
Avoid eyes, mucous membranes, exposure to sun. Treatment may be continued during antiinfective therapy. Reevaluate if no improvement after 10–14 days. Flammable.
Radiation therapy: may dissolve fuchsin dye; do not use 4 hours prior to session.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Outcomes in SCCHN Improved With Swap of Docetaxel for 5-FU in Palliative Regimen
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|